Abstract
Introduction
Usually coronary artery disease (CAD) can be diagnosed based on the results of non-invasive diagnostic methods. They help determine the coronary flow reserve, myocardial haemodynamics and possibly define patient's eligibility for an invasive diagnostic procedure, mostly coronary angioraphy. Not only are they helpful in diagnosing and choosing the best treatment, but they also have prognostic value. A prognosis means the anticipated course of disease and the prospect of specific events. In the case of CAD, myocardial infarct or cardiac death, i.e. so-called major cardiac events, revascularisation or emergence of unstable CAD, i.e. so-called minor cardiac events, are mostly taken into consideration. The applied diagnostic procedures can have a different prognostic value, also referred to as a predictive value of a test, in assessing the probability of an event.
The diagnostic procedures applied in the case of CAD patients are frequently complementary methods. The objective is to select a method or methods most appropriate in a given clinical situation. Myocardial perfusion scintigraphy (MPS) is a procedure which enables assessing the impairment of the coronary circulation. Patients with indications for MPS can be divided into several groups: patients suspected of CAD, those diagnosed with stable CAD, patients status post such cardiac events as infarct and/or revascularisation, status ante revascularisation for the assessment of myocardial viability, patients with an acute coronary episode after thrombolytic therapy. In the recent years, the prognosis and assessment of the risk of cardiac events was considered another indication for MPS [1] . The high prognostic value of MPS was confirmed in a number of papers, regardless of the applied radiopharmaceuticals and stress protocols. The risk of major cardiac events increases in proportion to the number of segments with reversible or persistent ischemia [2] [3] [4] . The aim of this paper is to determine the prognostic value of Tc-99m-MIBI MPS for patients suspected of and diagnosed with coronary artery disease.
Material and methods
The study group included 215 patients, 134 males and 81 females, aged 21-66, mean age 48 ± 9 (SD), status post myocardial perfusion scintigraphy. All the patients provided information on their further history during the observation period of 36-86 months, mean duration 52 months.
The patients were divided into the following two groups:
-Group I -suspected coronary artery disease -124 patients aged 21- patients within up to half a year, 16 patients within more than six months to one year, and 36 patients within more than one year prior to the examination. Revascularisation was performed in a total of 52 patients, in 38 within up to one year, and in 14 within more than one year prior to MPS. The above groups are characterised in Table 1 .
For all the patients suspected of CAD, without infarct, revascularisation and with normal coronary angiography results, the probability of CAD was calculated using the Diamond method, i.e.
based on their age, sex and type of complaints. The patients were divided according to the results into groups with a low, medium and high risk of CAD: from 0 to 0.30 -low risk, 0.31 to 0.70 -medium risk, more than 0.71 -high risk of coronary artery disease.
MPS was performed according to a two-day protocol. Scintigraphy at rest involved IV administration of 700-800 MBq of Tc-99m-MIBI, SPECT images were acquired within 40-60 minutes after the administration of the radiopharmaceutical. Stress test was performed according to the Bruce protocol, where physical stress test was combined with IV administration of dipyridamole. The physical stress test was terminated when patients achieved at least 85% of the heart rate limit or positive test features were observed.
One minute prior to the anticipated termination, 700-800 MBq of Tc-99m-MIBI was administered intravenously. Post-stress SPECT images were acquired, similarly as during the test at rest, within 40-60 minutes after the administration of the radiopharmaceutical.
All the examinations were registered with a Picker gamma camera, Dyna Pro SX-300. Tomographic profiles were reconstructed by back projection using first Metz filter, and then median filter. A series of images along the cardiac short axis were obtained -frontal, horizontal and sagittal images as well as two series of long-axis images.
Information about the patients' history in the defined obser- 
Results
The involvement of one segment was observed in 27 (12%) patients, of two segments in 24 (11%) patients, of three segments in 21 (10%) patients, of four segments in 19 (9%) patients, and of more than four segments in 15 (7%) patients. Reversible ischemia of one segment was determined in 31 (14%) patients, of two segments in 27 (12%) patients, of three segments in 20 (10%) patients, and of four segments in 6 (3%) patients. Irreversible ischemia of one segment was detected in 24 (11%) patients, of two segments in 22 (10%) patients, of three segments in 11 (5%) patients, and of four segments in 5 (2%) patients. The results according to the number of segments with irreversible and reversible ischemia, and the total number of the involved segments, irrespective of the pathology, are shown in Figure 1 for Group I and in Figure 2 for Group II. Group I included a significant number of patients with reversible ischemia which can be attributed to the type of patients -these are patients suspected of coronary artery disease, without any past coronary episodes determined in the interview, prior to any revascularisation treatment. On the other hand, Group II was dominated by patients with irreversible ischemia and there were also more patients with a greater number of involved segments. In Group I, there was only one patient with more than 4 segments involved, while in Group II, there were fourteen such patients.
The type of applied treatment, complaints and cardiac events reported in Group I, broken down into normal and pathological MPS results, are shown in Table 2 . The average observation period for the group with normal MPS results was 58 months.
In the case of the group with pathological MPS results, the observation period was shorter -only 38 months. Coronary angiography was performed for a similar number of patients in tients were found to suffer from reversible ischemia, 7 patients were found to have a cicatrix and related reversible ischemia, and 2 patients -a cicatrix within the left-ventricular muscle. In the case of these patients the number of segments involved was 3 or more.
For patients from Group I, i.e. patients suspected of CAD, without documented coronary episodes, the probability of CAD was calculated using the Diamond method at the interview stage. Figure 3 shows the occurrence of cardiac events for the groups of patients with a low risk of CAD from 0 to 30%, a medium risk from 31 to 70% and a high risk from 71 to 99%. These groups were also divided according to normal and pathological MPS results.
The risk level for patients from Group II, i.e. patients diagnosed with CAD, was defined as 100%. As shown in the figure, cardiac events occur mostly in the groups with a medium and high risk of CAD and in the group of patients diagnosed with CAD. Apart from one revascularisation, they were observed in the case of patients with pathological MPS results. Infarcts and deaths occurred relatively evenly during the entire observation period, while 
Discussion
The initial probability of coronary artery disease can play an important role when selecting the benchmark diagnostic procedure or treatment and also when interpreting diagnostic test results. The initial probability can be so high that positive test results will contribute little diagnostic information, and there will be a risk of falsely negative results. Therefore patients with a strong initial probability of CAD are directly referred for coronary angiography. In the case of patients without risk factors, and a low initial probability of CAD, family history of coronary artery disease. The greater the number of risk factors, the greater the probability of CAD [7] .
In the recent literature, some authors [2, 3, 5] have discussed the current role of diagnostic test in assessing the prognosis of cardiac events. For a prognostic test to be useful, it must be highly specific, it should minimise the number of falsely positive results, which are rather frequent when prognostic tests are applied to a healthy population, it must be adequately sensitive so that negative results exclude the probability of an event to the grea- to those with normal results [13] .
In a number of studies it was confirmed that as in Tl tion were reported in this period [16] . This study was based on SPECT procedure, and the observation period was to a significant extent longer compared to that applied in the above-mentioned studies. 7 patients with clinically significant stenosis as determined in coronary angiography had normal MPS results; in a relatively long observation period of more than 52 months, no major cardiac events occurred; and 2 patients underwent revascularisation.
The meta-analysis carried out by Iskander et al. [17] which included a total of 12 360 patients, both males and females, with stable CAD showed that patients with pathological MPS results carry the risk of cardiac events at 7.4% per year which corresponds to the obtained results. In accordance with the world medical literature it was shown that the risk of cardiac events grows in proportion to the area of impaired perfusion. Amanullah pointed out that the assessment of the vascular regions where perfusion is impaired contributes to the prognostic value of MPS [18] which is substantially compatible with our results.
As any other study, also this one is subject to some limitations.
One of them is the small number of patients in each study group.
But at the same time these are diverse groups, created based on day-to-day clinical practice, with patients who underwent SPECT MPS and were analysed according to normal and pathological MPS results . A number of patients with pathological results underwent no revascularisation or even coronary angiography, thus it can be considered an assessment of the natural course of the disease. Kamianek et al. suggested that it would be useful to include an additional parameter, such as pulmonary uptake [19] .
No such parameters were analysed in this study. The currently used diagnostic standard in most centres is SPECT-based ECG-gated MPS (GatedSPECT) as it enables assessing the ejection fraction of the left ventricle and segmental disorders of myocardial contractility. The knowledge of these data increases the sensitivity and specificity of the method, and thus the prognostic value of the examination [20] . At the time of the study commencement, our centre had no GSPECT equipment.
Numerous authors confirmed the strong prognostic value of MPS, however, a significant majority of the available studies were related to populations of both females and males, frequently with a higher percentage of males in the study groups. The studies designed and conducted selectively on a female population suggest a higher prognostic value of myocardial perfusion scintigraphy, however, they are much less numerous and still under investigation [21, 22] . The problem of sex-dependent prognostic value of MPS is of interest to the authors of this paper, however, it would require a separate study due to its scope. 2. Pathological MPS results clearly imply a greater risk of cardiac events; at the same time the number of events increases with the greater probability of CAD and with the patient's age.
3. Normal MPS results, even with significant changes determined in coronary angiography (coronary stenosis), imply a very low risk of cardiac events.
